CIK 0001604191
- Non-accelerated filer
- Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464993860
- Phone
- +1 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- 4 Grant or award Chairman, President and CEO acquired 37,660 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 19,614 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,676 shares at $0.29 ($486)
- 4 Open-market sale President and CEO sold 2,764 shares at $0.29 ($802)
- 4 Open-market sale Director sold 10 shares at $0.43 ($4)
- 4 Open-market sale Director sold 6,053 shares at $0.30 ($1,816)
- 4 Open-market sale Chief Financial Officer sold 1,977 shares at $1.54 ($3,045)
- 4 Open-market sale President and CEO sold 3,349 shares at $1.54 ($5,157)
- 4 Open-market sale Chief Financial Officer sold 1,975 shares at $2.50 ($4,938)
- 4 Open-market sale President and CEO sold 3,347 shares at $2.50 ($8,368)
- 4 Grant or award Director acquired 84,745 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Director acquired 84,745 shares (grant or award)
- 4 Grant or award Director acquired 84,745 shares (grant or award)
- 4 Grant or award Director acquired 84,745 shares (grant or award)
- 4 Grant or award Director acquired 84,745 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 10 · 181 filings